Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

Subjects

Subjects :

proteasome
peptide splicing
antigen presentation
tumor immunology
mass spectrometry
Immunologic diseases. Allergy
RC581-607

Details

Language :

English

ISSN :

16643224

Volume :

12

Database :

Directory of Open Access Journals

Journal :

Frontiers in Immunology

Publication Type :

Academic Journal

Accession number :

edsdoj.00d8bd3da842e7b734fbc4cc606cba

Document Type :

article

Full Text :

https://doi.org/10.3389/fimmu.2021.679836